In honor of SMA Awareness Month, we are pleased to introduce a new collection!
Muscular Atrophy (SMA) is a genetic disorder that causes severe muscle
weakness which affects the ability to move, stand, sit, cough, swallow,
and breathe. It is the number one genetic killer of children under
the age of two, affecting approximately 1 in 6,000 births. SMA is an
autosomal recessive disorder, so a child must get the defective gene
from both parents to be affected by the disease. Approximately 1 in 40
people unknowingly carry the gene responsible for SMA. SMA does not
discriminate - it affects people of all races, ethnicities, and
genders. SMA does not affect intelligence.
are several subtypes of SMA based on age of onset and severity of
symptoms. Type 1 is the most severe, type 4 the least. 60% of SMA
births are type 1. The prognosis for each type varies, but in all
cases, it is a progressive, degenerative disease that can take away a
person’s ability to walk, stand, sit, eat, and breathe. 2017 brought
news of a promising new treatment, Spinraza, but there is currently no
cure. Even with this treatment, people with SMA require various
therapies and interventions to survive and thrive, often at enormous
costs, even with good insurance.
A portion of the proceeds
from each sale from the SMA collection will provide start-up funds for a
new non-profit organization dedicated to providing medical insurance
advocacy services at no charge to people with SMA.